{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:09Z","timestamp":1791388089509,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1067\/mai.2001.114239","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:20:53Z","timestamp":1027570853000},"page":"751-762","source":"Crossref","is-referenced-by-count":142,"title":["Desloratadine: A new, nonsedating, oral antihistamine"],"prefix":"10.1067","volume":"107","author":[{"given":"Raif S.","family":"Geha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli O.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1067\/mai.2001.114239_bib1","first-page":"3","article-title":"Epidemiology of rhinitis and asthma","volume":"28","author":"Lundback","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2001.114239_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/108854100778248971","article-title":"Allergic rhinitis: epidemiology and natural history","volume":"21","author":"Schoenwetter","year":"2000","journal-title":"Allergy Asthma Proc"},{"key":"10.1067\/mai.2001.114239_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","article-title":"Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.114239_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis","volume":"55","author":"van Cauwenberge","year":"2000","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.114239_bib5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1136\/bmj.320.7243.1184","article-title":"Sedation with \u201cnon-sedating\u201d antihistamines: four prescription-event monitoring studies in general practice","volume":"320","author":"Mann","year":"2000","journal-title":"BMJ"},{"key":"10.1067\/mai.2001.114239_bib6","first-page":"292","article-title":"Pharmacokinetic overview of oral second-generation H1 antihistamines","volume":"36","author":"Gonzalez","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1067\/mai.2001.114239_bib7","series-title":"Physicians\u2019 desk reference","first-page":"3147","author":"Astelin","year":"2000"},{"key":"10.1067\/mai.2001.114239_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0149-2918(00)88286-7","article-title":"Second-generation antihistamines: the risk of ventricular arrhythmias","volume":"21","author":"DuBuske","year":"1999","journal-title":"Clin Ther"},{"key":"10.1067\/mai.2001.114239_bib9","first-page":"866","article-title":"OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine","volume":"27","author":"Cvetkovic","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1067\/mai.2001.114239_bib10","series-title":"Physicians\u2019 desk reference","first-page":"2404","author":"Zyrtec","year":"2000"},{"key":"10.1067\/mai.2001.114239_bib11","first-page":"345","article-title":"Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects","volume":"50","author":"Kreutner","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1067\/mai.2001.114239_bib12","unstructured":"Affrime M, Gupta S, Banfield C, Rosenberg M, Cohen A. A pharmacokinetic profile of desloratadine in healthy adults including elderly subjects. Clin Pharmacokinet. In press."},{"key":"10.1067\/mai.2001.114239_bib13","first-page":"277","article-title":"Functional characterization of desloratadine and other antihistamines in human histamine H1 receptors","volume":"55","author":"Anthes","year":"2000","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.114239_bib14","doi-asserted-by":"crossref","unstructured":"Schroeder JT, Schleimer RP, Lichtenstein LM, Kreutner W. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy. In press.","DOI":"10.1046\/j.1365-2222.2001.01130.x"},{"key":"10.1067\/mai.2001.114239_bib15","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2222.1997.tb00745.x","article-title":"Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FceRI+ cells","volume":"27","author":"Genovese","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1067\/mai.2001.114239_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0625.1995.tb00257.x","article-title":"Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist descarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines","volume":"4","author":"Lippert","year":"1995","journal-title":"Exp Dermatol"},{"key":"10.1067\/mai.2001.114239_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1398-9995.1995.tb01133.x","article-title":"Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells","volume":"50","author":"Vignola","year":"1995","journal-title":"Allergy"},{"issue":"Suppl 63","key":"10.1067\/mai.2001.114239_bib18","first-page":"276","article-title":"Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation","volume":"55","author":"Agrawal","year":"2000","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.114239_bib19","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF01978891","article-title":"Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine","volume":"14","author":"Barnett","year":"1984","journal-title":"Agents Actions"},{"key":"10.1067\/mai.2001.114239_bib20","first-page":"441","article-title":"Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: 2nd communication: lack of central nervous system and cardiovascular effects","volume":"50","author":"Kreutner","year":"2000","journal-title":"Arzneimittelforschung"},{"key":"10.1067\/mai.2001.114239_bib21","unstructured":"Gupta S, Banfield C, Affrime M, Marco A, Cayen M, Herron J, et al. Desloratadine demonstrates dose proportionality in healthy adults. Clin Pharmacokinet. In press."},{"key":"10.1067\/mai.2001.114239_bib22","doi-asserted-by":"crossref","unstructured":"Gupta S, Banfield C, Affrime M, Padhi D, Marbury T, Glue P. Oral bioavailability of desloratadine is unaffected by food. Clin Pharmacokinet. In press.","DOI":"10.2165\/00003088-200241001-00002"},{"key":"10.1067\/mai.2001.114239_bib23","unstructured":"Banfield C, Hunt T, Reyderman L, Statkevich P, Padhi D, Affrime M. Lack of interaction between desloratadine and erythromycin. Clin Pharmacokinet. In press."},{"key":"10.1067\/mai.2001.114239_bib24","unstructured":"Banfield C, Herron J, Keung A, Padhi D, Affrime M. Desloratadine has no electrocardiographic or pharmacodynamic interactions with ketoconazole. Clin Pharmacokinet. In press."},{"key":"10.1067\/mai.2001.114239_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/00912709922012006","article-title":"The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions","volume":"39","author":"Yu","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1067\/mai.2001.114239_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200002000-00029","article-title":"Role of P-glycoprotein in drug disposition","volume":"22","author":"Tanigawara","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1067\/mai.2001.114239_bib27","first-page":"135","article-title":"P-Glycoprotein","author":"Silverman","year":"2000"},{"issue":"Suppl 63","key":"10.1067\/mai.2001.114239_bib28","first-page":"282","article-title":"Effect of desloratadine on p-glycoprotein transport system (MDR1)","volume":"55","author":"Cayen","year":"2000","journal-title":"Allergy"},{"key":"10.1067\/mai.2001.114239_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/cp.1999.v66.a101944","article-title":"Pharmacokinetic interaction of digoxin with an herbal extract from St John\u2019s wort (Hypericum perforatum)","volume":"66","author":"Johne","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1067\/mai.2001.114239_bib30","first-page":"108","article-title":"Grapefruit juice has no effect on the oral bioavailability of desloratadine, but reduces the Cmax and AUC of fexo-fenadine by 30%","volume":"86","author":"Banfield","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.114239_bib31","doi-asserted-by":"crossref","unstructured":"Affrime M, Banfield C, Gupta S, Rosenberg M, Cohen A, Boutros T, et al. Effect of race and sex on single- and multiple-dose pharmacokinetics of desloratadine. Clin Pharmacokinet. In press.","DOI":"10.2165\/00003088-200241001-00004"},{"key":"10.1067\/mai.2001.114239_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00044011-200121010-00004","article-title":"Efficacy and safety of once-daily 5 mg desloratadine, a potent histamine H1-receptor antagonist, in patients with seasonal allergic rhinitis. Assessment during the spring and fall allergy seasons","volume":"21","author":"Meltzer","year":"2001","journal-title":"Clin Drug Invest"},{"key":"10.1067\/mai.2001.114239_bib33","article-title":"Desloratadine is effective at relieving nasal congestion, as demonstrated in three placebo-controlled trials in patients with seasonal allergic rhinitis","author":"Lorber","year":"2001","journal-title":"New Trends Allergy"},{"key":"10.1067\/mai.2001.114239_bib34","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1081-1206(10)62612-9","article-title":"National guidelines needed to manage rhinitis and prevent complications","volume":"82","author":"Rachelefsky","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.114239_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2500\/108854199778339026","article-title":"Pharmacotherapy to prevent the complications of allergic rhinitis","volume":"20","author":"Beckman","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1067\/mai.2001.114239_bib36","first-page":"110","article-title":"Desloratadine improved SAR symptoms in patients with mild-to-moderate asthma and SAR","volume":"86","author":"Schenkel","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.114239_bib37","first-page":"109","article-title":"Desloratadine improved asthma symptoms and reduced bronchodilator use in 2 studies of patients with asthma and SAR","volume":"86","author":"Ratner","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1067\/mai.2001.114239_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-4362.2001.00186.x","article-title":"Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double-blind, placebocontrolled study","volume":"40","author":"Ring","year":"2001","journal-title":"Int J Dermatol"},{"issue":"Suppl 63","key":"10.1067\/mai.2001.114239_bib39","first-page":"280","article-title":"Desloratadine has no effect on wakefulness or psychomotor performance","volume":"55","author":"Scharf","year":"2000","journal-title":"Allergy"},{"issue":"Suppl 63","key":"10.1067\/mai.2001.114239_bib40","first-page":"263","article-title":"Desloratadine does not impair actual driving performance: a 3-way crossover comparison with diphenhydramine and placebo","volume":"55","author":"Vuurman","year":"2000","journal-title":"Allergy"},{"issue":"Suppl 63","key":"10.1067\/mai.2001.114239_bib41","first-page":"277","article-title":"Desloratadine and alcohol co-administration: no increase in impairment of performance over that induced by alcohol alone","volume":"55","author":"Rikken","year":"2000","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901936437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674901936437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:53:56Z","timestamp":1557402836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674901936437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["S0091674901936437"],"URL":"https:\/\/doi.org\/10.1067\/mai.2001.114239","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}